Clinical Trial Update: Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors

View source ↗

Summary

A clinical study evaluating 68Ga-DOTA-BLP PET imaging for the noninvasive diagnosis of malignant tumors. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-DOTA-BLP

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Canser | Status: NOT_YET_RECRUITING